Dabigatran, rivaroxaban, or apixaban versus warfarin in patients with nonvalvular atrial fibrillation: a systematic review and meta‐analysis of subgroups
A Gómez-Outes, AI Terleira-Fernández… - …, 2013 - Wiley Online Library
Background. New oral anticoagulants (NOAC; rivaroxaban, dabigatran, apixaban) have
become available as an alternative to warfarin anticoagulation in non‐valvular atrial …
become available as an alternative to warfarin anticoagulation in non‐valvular atrial …
Dabigatran, Rivaroxaban, or Apixaban versus Warfarin in Patients with Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Subgroups.
A Gómez-Outes, AI Terleira-Fernández… - …, 2013 - search.ebscohost.com
Background. New oral anticoagulants (NOAC; rivaroxaban, dabigatran, apixaban) have
become available as an alternative to warfarin anticoagulation in non-valvular atrial …
become available as an alternative to warfarin anticoagulation in non-valvular atrial …
Dabigatran, Rivaroxaban, or Apixaban versus Warfarin in Patients with Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Subgroups
A Gómez-Outes, AI Terleira-Fernández… - …, 2013 - pubmed.ncbi.nlm.nih.gov
Background. New oral anticoagulants (NOAC; rivaroxaban, dabigatran, apixaban) have
become available as an alternative to warfarin anticoagulation in non-valvular atrial …
become available as an alternative to warfarin anticoagulation in non-valvular atrial …
Dabigatran, rivaroxaban, or apixaban versus warfarin in patients with nonvalvular atrial fibrillation: a systematic review and meta-analysis of subgroups
A Gomez-Outes, AI Terleira-Fernandez, G Calvo-Rojas… - Thrombosis, 2014 - go.gale.com
Background. New oral anticoagulants (NOAC; rivaroxaban, dabigatran, apixaban) have
become available as an alternative to warfarin anticoagulation in non-valvular atrial …
become available as an alternative to warfarin anticoagulation in non-valvular atrial …
[PDF][PDF] Dabigatran, Rivaroxaban, or Apixaban versus Warfarin in Patients with Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Subgroups
A Gómez-Outes, AI Terleira-Fernández, G Calvo-Rojas… - 2013 - pdfs.semanticscholar.org
Background. New oral anticoagulants (NOAC; rivaroxaban, dabigatran, apixaban) have
become available as an alternative to warfarin anticoagulation in non-valvular atrial …
become available as an alternative to warfarin anticoagulation in non-valvular atrial …
[PDF][PDF] Dabigatran, Rivaroxaban, or Apixaban versus Warfarin in Patients with Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Subgroups
A Gómez-Outes, AI Terleira-Fernández, G Calvo-Rojas… - 2013 - portailvasculaire.fr
Background. New oral anticoagulants (NOAC; rivaroxaban, dabigatran, apixaban) have
become available as an alternative to warfarin anticoagulation in non-valvular atrial …
become available as an alternative to warfarin anticoagulation in non-valvular atrial …
[HTML][HTML] Dabigatran, Rivaroxaban, or Apixaban versus Warfarin in Patients with Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Subgroups
A Gómez-Outes, AI Terleira-Fernández… - Thrombosis, 2013 - ncbi.nlm.nih.gov
Background. New oral anticoagulants (NOAC; rivaroxaban, dabigatran, apixaban) have
become available as an alternative to warfarin anticoagulation in non-valvular atrial …
become available as an alternative to warfarin anticoagulation in non-valvular atrial …
Dabigatran, Rivaroxaban, or Apixaban versus Warfarin in Patients with Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Subgroups
A Gómez-Outes, AI Terleira-Fernández, G Calvo-Rojas… - Thrombosis, 2013 - cir.nii.ac.jp
抄録< jats: p>< jats: italic> Background</jats: italic>. New oral anticoagulants (NOAC;
rivaroxaban, dabigatran, apixaban) have become available as an alternative to warfarin …
rivaroxaban, dabigatran, apixaban) have become available as an alternative to warfarin …
[HTML][HTML] Dabigatran, Rivaroxaban, or Apixaban versus Warfarin in Patients with Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Subgroups.
A Gómez-Outes, AI Terleira-Fernández… - Thrombosis, 2013 - europepmc.org
Background. New oral anticoagulants (NOAC; rivaroxaban, dabigatran, apixaban) have
become available as an alternative to warfarin anticoagulation in non-valvular atrial …
become available as an alternative to warfarin anticoagulation in non-valvular atrial …
Dabigatran, Rivaroxaban, or Apixaban versus Warfarin in Patients with Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Subgroups.
A Gómez-Outes, AI Terleira-Fernández… - Thrombosis, 2013 - europepmc.org
Background. New oral anticoagulants (NOAC; rivaroxaban, dabigatran, apixaban) have
become available as an alternative to warfarin anticoagulation in non-valvular atrial …
become available as an alternative to warfarin anticoagulation in non-valvular atrial …